News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Genetic flaw may hold key to deadly childhood brain tumour
ICR researchers have found a surprising link between childhood glioma and rare genetic syndrome in which muscle turns to bone.
ICR researchers focus on smart treatments at leading cancer conference
ICR scientists are making the trip to San Diego this weekend for one of the biggest dates in the cancer calendar – the American Association of Cancer Research (AACR) conference.
Blood test could provide a representative measure of long term hormone levels
A single blood sample could predict hormone levels known to be an indicator of breast cancer risk for years to come, according to ICR researchers.
How cancer evolves sheds light on origin of breast cancer subtypes
ICR researchers find that multiple forms of breast cancer can originate from a single cell type, which could change how we target and treat the disease.
Statement in reaction to new proposals from NICE on end of life criteria
The ICR highlights the importance of the end of life criteria in the way NICE makes recommendations on new medicines, as it is important for cancer patients to access life-extending drugs.
High-tech ultrasound scan could match tumour tracking power of CyberKnife
A new type of ultrasound imaging could potentially follow tumour movements as well as the X-ray tracking used in the sophisticated radiotherapy technology CyberKnife, allowing precise targeting of radiation doses, new research concludes.
Gut bacteria clinical study could help reduce radiotherapy side-effects
ICR researchers will examine how gut bacteria influences the side-effects patients experience after radiotherapy, in the first clinical study of its type.
Professor Andrew Tutt to head Breakthrough Breast Cancer Research Centre
Leading expert in clinical trials and targeted therapies for breast cancer joins the ICR as Centre Director for the Breakthrough Toby Robins Breast Cancer Research Centre.
Gene test finds breast cancer patients who may benefit from longer therapy
Some postmenopausal women with ER+ breast cancer may benefit from ten years of hormone therapy instead of five, says ICR researcher.
Cancer study sheds new light on premature menopause
Around two per cent of women with primary ovarian insufficiency – the medical term for a permanent halt in menstruation occurring naturally before the age of 40 – are affected by changes to a particular gene, a study has shown.
ICR scientists pioneer new skin cancer elastography imaging
Institute of Cancer Research scientists have developed a new technique to analyse skin lesions by looking at how tissues move when they are stretched.
Prof Alan Ashworth appointed Director of UCSF Helen Diller Cancer Center
Chief exec who reinforced the ICR's position among the world's top cancer research centres will lead San Francisco Comprehensive Cancer Center from 2015.
